NASDAQ:APRE

Aprea Therapeutics, Inc.

Stock

USD

Last Close

3.81

26/07 20:00

Market Cap

21.45M

Beta: -

Volume Today

3.70K

Avg: 15.86K

PE Ratio

−0.19

PFCF: −1.88

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-15.19M -	-15.53M 2.23%	-28.06M 80.70%	-53.48M 90.59%	-37.13M 30.58%	-112.66M 203.45%	-14.29M 87.32%
depreciation and amortization	7.93K -	8.32K 4.84%	170.25K 1,947.31%	229.61K 34.86%	271.68K 18.32%	186.44K 31.37%	7.05K 96.22%
deferred income tax							-827.46K -
stock based compensation	395.44K -	329.18K 16.76%	1.35M 308.81%	4.98M 270.29%	7.81M 56.81%	16.98M 117.33%	444.46K 97.38%
change in working capital	1.45M -	901.85K 37.67%	1.16M 28.99%	5.57M 379.10%	-8.33M 249.41%	-1.76M 78.88%	827.46K 147.05%
accounts receivables
inventory
accounts payables	327.05K -	214.38K 34.45%	437.51K 104.08%	2.33M 431.81%	-2.73M 217.36%	-858.51K 68.56%	827.46K 196.38%
other working capital	1.12M -	687.47K 38.61%	725.75K 5.57%	3.25M 347.33%	-5.60M 272.38%	-900.07K 83.92%	-827.46K 8.07%
other non cash items	-662.14K -	-961.32K 45.18%	-1.33M 38.16%	890.25K 167.03%	-317.40K 135.65%	72.24M 22,860.34%	830.17K 98.85%
net cash provided by operating activities	-14.00M -	-15.25M 8.91%	-26.71M 75.14%	-41.80M 56.51%	-37.69M 9.85%	-25.01M 33.63%	-12.18M 51.31%
investments in property plant and equipment		-3.70K -	-30.90K 734.71%	-25.71K 16.80%			-93.09K -
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites		-3.70K -	-30.90K 734.71%	-25.71K 16.80%			-93.09K -
debt repayment
common stock issued			86.91M -	150.95K 99.83%	1.54M 919.31%	682.97K 55.61%	5.79M 747.61%
common stock repurchased
dividends paid
other financing activites	23.34M -	56.37M 141.46%	5.67M 89.94%		208.37K -		-648.93K -
net cash used provided by financing activities	23.34M -	56.37M 141.46%	92.58M 64.24%	150.95K 99.84%	1.75M 1,057.35%	682.97K 60.91%	5.14M 652.59%
effect of forex changes on cash	1.39M -	161.64K 88.41%	-1.42M 980.36%	606.25K 142.60%	-2.47K 100.41%	38.76K 1,671.06%	-8.40K 121.67%
net change in cash	10.74M -	41.27M 284.44%	64.41M 56.06%	-41.07M 163.76%	-35.94M 12.49%	-24.29M 32.42%	-7.14M 70.61%
cash at beginning of period	13.67M -	24.40M 78.57%	65.68M 169.15%	130.09M 98.08%	89.02M 31.57%	53.08M 40.38%	28.79M 45.76%
cash at end of period	24.40M -	65.68M 169.15%	130.09M 98.08%	89.02M 31.57%	53.08M 40.38%	28.79M 45.76%	21.65M 24.80%
operating cash flow	-14.00M -	-15.25M 8.91%	-26.71M 75.14%	-41.80M 56.51%	-37.69M 9.85%	-25.01M 33.63%	-12.18M 51.31%
capital expenditure		-3.70K -	-30.90K 734.71%	-25.71K 16.80%			-93.09K -
free cash flow	-14.00M -	-15.25M 8.94%	-26.74M 75.30%	-41.83M 56.43%	-37.69M 9.90%	-25.01M 33.63%	-12.27M 50.94%

All numbers in USD (except ratios and percentages)